Fas-induced apoptosis of renal cell carcinoma is mediated by apoptosis signal-regulating kinase 1 via mitochondrial damage-dependent caspase-8 activation

Cellular Oncology

Volumn 31, Issue 6, 2009, Pages 437-456

  Hassan, Mohamed ^a,b,c   Feyen, Oliver ^a   Grinstein, Edgar ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b INSERM   (France)

^c UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Apoptosis; ASK1; CH11; MAP kinase; RCC

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; APOPTOSIS SIGNAL REGULATING KINASE 1; CASPASE 8; CASPASE 9; FAS ASSOCIATED DEATH DOMAIN PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BAX; STRESS ACTIVATED PROTEIN KINASE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD95; APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CARCINOMA, RENAL CELL; CASPASE 8; CELL LINE, TUMOR; DNA DAMAGE; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; KIDNEY NEOPLASMS; MAP KINASE KINASE KINASE 5; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; MODELS, BIOLOGICAL; P38 MITOGEN-ACTIVATED PROTEIN KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1;

EID: 71949085193     PISSN: 15705870     EISSN: None     Source Type: Journal    
DOI: 10.1155/2009/108284     Document Type: Article

References (42)

1. A. Tavani and C. La Vecchia, Epidemiology of renal-cell carcinoma, J. Nephrol. 10 (1997), 93-106.
2. N.K. Janzen, H.L. Kim, R.A. Figlin and A.S. Belldegrun, Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease, Urol. Clin. North. Am. 30 (2003), 843-852. (Pubitemid 37485197)
3. M. Siegsmund, U. Brinkmann, E. Schaffeler, G. Weirich, M. Schwab, M. Eichelbaum, P. Fritz, O. Burk, J. Decker, P. Alken, U. Rothenpieler, R. Kerb, S. Hoffmeyer and H. Brauch, Association of the P-glycoprotein transporter DR1 (C3435T) polymorphism with the susceptibility to renal epithelial tumors, J. Am. Soc. Nephrol. 13 (2002), 1847-1854.
4. S. Oudard, C. Levalois, J.M. Andrieu, J. Bougaran, P. Validire, N. Thiounn, M.F. Poupon, E. Fourme and S. Chevillard, Expression of genes involved in chemoresistance, proliferation and apoptosis in clinical samples of renal cell carcinoma and correlation with clinical outcome, Anticancer Res. 22 (2002), 121-128.
5. J.M. Scheltema, J.C. Romijn, G.J. van Steenbrugge, F.H. Schröder and G.H. Mikisch, Inhibition of apoptotic proteins causes multidrug resistance in renal carcinoma cells, Anticancer Res. 21 (2001), 3161-3166.
6. B. Coppin, F. Porzsolt, A. Awa, J. Kumpf, A. Coldman and T. Wilt, Immunotherapy for advanced renal cell cancer, Cochrane Database Syst. Rev. 1 (2005), CD001425.
7. H. Seimiya, T. Mashima, M. Toho and T. Tsuruo, c-Jun NH2-terminal kinase-mediated activation of interleukin-1beta converting enzyme/CED-3-like protease during anticancer druginduced apoptosis, J. Biol. Chem. 272 (1997), 4631-4636.
8. H. Steller, Mechanisms and genes of cellular suicide, Science 276 (1995), 1445-1449.
9. A. Cosman, A family of ligands for the TNF receptor superfamily, Stem Cells 12 (1994), 440-455.
10. K. Schulze-Osthoff, D. Ferrari, M. Los, S. Wesselborg and M.E. Peter, Apoptosis signaling by death receptors, Eur. J. Biochem. 254 (1998), 439-459.
11. I. Herr, D.Wilhelm, T. Böhler, P. Angel and K.M. Debatin, Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis, EMBO J. 16 (1997), 6200-6208.
12. M. Itoh, C. Hiramine and K. Hojo, A new murine model of autoimmune orchitis induced by immunization with viable syngeneic testicular germ cells alone. I. Immunological and histological studies, Clin. Exp. Immunol. 83 (1991), 137-142.
13. J. Romashko, S. Horowitz, W.R. Franek, T. Palaia, E.J. Miller, A. Lin, M.J. Birrer, W. Scott and L.L. Mantell, MAPK pathways mediate hyperoxia-induced oncotic cell death in lung epithelial cells, Free Radic. Biol. Med. 35 (2003), 978-993.
14. A. Mansouri, L.D. Ridgway, A.L. Korapati, O. Zhang, L. Tian, Y. Wang, Z.H. Ziddik, G.B. Mills and F.X. Claret, Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells, J. Biol. Chem. 278 (2003), 19245-19256.
15. Y. Deng, X. Ren, L. Yang, Y. Lin and X.Wu, A JNK-dependent pathway is required for TNFalpha-induced apoptosis, Cell 115 (2003), 61-70.
16. S. Maruoka, S. Hashimoto, Y. Gon, H. Nishitoh, I. Takeshita, Y. Asai, K. Mizumura, K. Shimizu, H. Ichijo and T. Horie, ASK1 regulates influenza virus infection-induced apoptotic cell death, Biochem. Biophys. Res. Commun. 307 (2003), 870-876.
17. S. Yamagishi, M. Yamada, H. Koshimizu, S. Takai, H. Hatanaka, K. Takeda, H. Ichijo, K. Shimoke and T. Ikeuchi, Apoptosis-signal regulating kinase-1 is involved in the low potassium-induced activation of p38 mitogen-activated protein kinase and c-Jun in cultured cerebellar granule neurons, J. Biochem. (Tokyo) 133 (2003), 719-724.
18. K. Takeda, A. Matsuzawa, H. Nishitoh and H. Ichijo, Roles of MAPKKK ASK1 in stress-induced cell death, Cell Struct. Funct. 28 (2003), 23-29.
19. D. Selemovic, M. Hassan, Y. Haikel and U.R. Hengge, Taxolinduced mitochondrial stress in melanoma cells is mediated by activation of c-Jun N-terminal kinase (JNK) and p38 pathways via uncoupling protein 2, Cell. Signal. 20 (2008), 311-322.
20. M. Hassan, D. Selimovic, H. Ghozlan and O. Abdel-kader, Induction of high-molecular-weight (HMW) tumor necrosis factor (TNF) alpha by hepatitis C virus (HCV) non-structural protein 3 (NS3) in liver cells is AP-1 and NF-kappaB-dependent activation, Cell. Signal. 19 (2007), 301-311.
21. M. Hassan, H. Ghozlan and O. Abdel-kader, Activation of c-Jun NH2-terminal kinase (JNK) signaling pathway is essential for the stimulation of hepatitis C virus (HCV) nonstructural protein 3 (NS3)-mediated cell growth, Virology 333 (2005), 324-336.
22. M. Hassan, A. Alaoui, O. Feyen, A. Mirmohammadsadegh, F. Essmann, A. Tannapfel, E. Gulbins, K. Schulze-Osthoff and U.R. Hengge, The BH3-only member Noxa causes apoptosis in melanoma cells by multiple pathways, Oncogene 27 (2008), 4557-4568.
23. M. Hassan, A. Mirmohammadsadegh, D. Selimovic, S. Nambiar, A. Tannapfel and U.R. Hengge, Cell. Mol. Life Sci. 62 (2005), 2015-2026.
24. A.S. Buchau, M. Hassan, G. Kukova, V. Lewerenz, S. Kellermann, J.U.Wurthner, R.Wolf,M.Walz, R.L. Gallo and T. Ruzicka, S100A15, an antimicrobial protein of the skin: regulation by E. coli through Toll-like receptor 4, Invest. Dermatol. 127 (2007), 2596-2604.
25. A.C. Sobke, D. Selimovic, V. Orlova, M. Hassan, T. Chavakis, A.N. Athanasopoulos, U. Schubert, M. Hussain, G. Thiel, K.T. Preissner and M. Herrmann, The extracellular adherence protein from Staphylococcus aureus abrogates angiogenic responses of endothelial cells by blocking Ras activation, FASEB J. 20 (2006), 2621-2623.
26. Y. Li, A.J. Raffo, L. Drew, Y. Mao, A. Tran, D.P. Petrylak and R.L. Fine, Fas-mediated apoptosis is dependent on wild-type p53 status in human cancer cells expressing a temperature-sensitive p53 mutant alanine-143, Cancer Res. 63 (2003), 1527-1533.
27. A. Hueber,M.Weller, G.Welsandt, N. Kociok, B. Kirchhof and P. Esser, Characterization of daunorubicin-induced apoptosis in retinal pigment epithelial cells: modulation by CD95L, Invest. Ophthalmol. Vis. Sci. 44 (2003), 2851-2857. (Pubitemid 36759744)
28. J. Guillermet, N. Saint-Laurent, P. Rochaix, O. Cuvillier, T. Levade, A.V. Schally, L. Pradayrol, L. Buscail, C. Susini and C. Bousquet, Somatostatin receptor subtype 2 sensitizes human pancreatic cancer cells to death ligand-induced apoptosis, Proc. Natl. Acad. Sci. USA 100 (2003), 155-160. (Pubitemid 36078044)
29. N.M. Mhaidat, Y. Wang, K.A. Kiejda and X.D. Zhang, On activation of caspase-2, Mol. Cancer Ther. 6 (2007), 752-761.
30. G.J. Griffiths, L. Dubrez, C.P. Morgan, N.A. Jones, J. Whitehouse, B.M. Corfe, C. Dive and J.A. Hickman, Cell damageinduced conformational changes of the pro-apoptotic protein Bak in vivo precedes the onset of apoptosis, Cell Biol. 144 (1999), 903-914.
31. G. Dewson, R.T. Snowden, J.B. Almond and M.J. Dyer, Conformational changes and mitochondrial translocation of Bax accompany proteosome inhibitor induced apoptosis of chronic lymphocytic leukemia cells, Oncogene 22 (2003), 2643-2654.
32. S. Nagata, Apoptosis by death factor, Cell 88 (1997), 355-356.
33. S. Heikaus, L. van den Berg, T. Kempf, C. Mahotka, H.E. Gabbert and U. Ramp, HA14.1 is able to reconstitute the impaired mitochondrial pathway of apoptosis in renal cell carcinoma cell lines, Cell. Oncol. 30 (2008), 419-433.
34. D.M. Heijink, J.H. Kleibeuker, M. Jalving, W. Boersma-van Ek, J.J. Koornstra, J. Wesseling and S. de Jong, Independent induction of caspase-8 and cFLIP expression during colorectal carcinogenesis in sprodic and HNPCC adenomas and carcinomas, Cell. Oncol. 29 (2007), 409-419.
35. X. Yang, R. Khosravi-Far, H.Y. Chang and D. Baltimore, Daxx, a novel Fas-binding protein that activates JNK and apoptosis, Cell 89 (1997), 1067-1076.
36. H.Y. Chang, H. Nishitoh, X. Yang, H. Ichijo and D. Baltimore, Activation of apoptosis signal-regulating kinase 1 (ASK1) by the adapter protein Daxx, Science 281 (1998), 1860-1863. (Pubitemid 28450508)
37. G.B. Lesinski, E.T. Raig, K. Guenterberg, L. Brown, M.R. Go, N.N. Shah, A. Lewis, E. Hade, G. Young, A.R. Chaudhury, K.J. Ladner, D.C. Guttridge, P. Bouchard and W.E. Carson, IFN-alpha and bortezomib overcome Bcl-2 and Mcl-1 overexpression in melanoma cells by stimulating the extrinsic pathway of apoptosis, Cancer Res. 68 (2008), 8351-8360.
38. C. Tournier, P. Hess, D.D. Yang, J. Xu, T.K. Turner, A. Nimnual, D. Bar-Sagi, S.N. Jones, R.A. Flavell and R.J. Davis, Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway, Science 288 (2000), 870-874.
39. A. Bhattacharyya, S. Pathak, C. Basak, S. Law, M. Kundu and J. Basu, Execution of macrophage apoptosis by Mycobacterium avium through apoptosis signal-regulating kinase 1/p38 mitogen-activated protein kinase signaling and caspase 8 activation, Biol. Chem. 278 (2003), 26517-26525.
40. G.S. Salvesen and V.M. Dixit, Caspases: intracellular signaling by proteolysis, Cell 91 (1997), 443-446.
41. H. Li, H. Zhu, C.J. Xu and J. Yuan, Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis, Cell 94 (1998), 491-501.
42. C. Tan, P.J. Dlugosz, J. Peng, Z. Zhang, S.M. Lapolla, S.M. Plafker, D.W. Andrews and J. Lin, J. Biol. Chem. 281 (2006), 14764-14775.